Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Initial review, 17410 [2013-06436]
Download as PDF
<![CDATA[
17410
Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices
Proposed Project
Prevention Research Centers Program
National Evaluation Reporting System—
Revision—Division of Population
Health, National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Prevention Research Centers
(PRC) Program was established by
Congress through the Health Promotion
and Disease Prevention Amendments of
1984. PRCs conduct outcomes-oriented
health promotion and disease
prevention research on a broad range of
topics using a multi-disciplinary and
community-based approach. CDC
manages the PRC Program and currently
provides funding to PRC grantees that
are housed within schools of public
health, medicine or osteopathy. Awards
are made for five years and may be
renewed through a competitive
application process.
CDC is currently approved to collect
performance information from PRCs
through a web-based survey and
telephone interview (OMB #0920–0650,
exp. 6/30/2013). The web-based survey
is designed to collect information on the
PRCs’ collaborations with health
departments; formal training programs
and other training activities; and other
funded prevention research projects
conducted separately from their core
research. A structured telephone
interview with a key PRC informant
obtains information on systems and
environmental changes in which PRCs
are involved. The content of the
information collection is guided by a set
of performance indicators developed
(2002) and later revised (2009) in
collaboration with the PRCs.
CDC requests OMB approval to
continue conducting the annual webbased survey and the annual interview.
Changes to be implemented include (1)
changing the platform of the web-based
survey, (2) reducing the number of
questions asked on each instrument,
and (3) revising some questions for
clarity or to reflect the current needs
and priorities of the program. The
proposed changes will result in a net
decrease in burden to respondents.
OMB approval is requested for a
three-year period with a start date of
June 1, 2013. There are no costs to
respondents other than their time. The
total estimated burden hours are 204.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
Form name
PRC Program .........................................
Survey ...................................................
Telephone Interview ..............................
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director.
[FR Doc. 2013–06493 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK67QTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Initial review
The meeting announced below
concerns Epi-Centers for the Prevention
of Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events, Funding Opportunity
Announcement (FOA) CK11–
0010301SUPP13, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
15:09 Mar 20, 2013
Jkt 229001
37
37
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Epi-Centers for the Prevention
of Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events, FOA CK11–0010301SUPP13’’.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06436 Filed 3–20–13; 8:45 am]
BILLING CODE 4163–18–P
Time and Date: 1:00 p.m.–4:00 p.m., May
8, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
VerDate Mar<14>2013
PO 00000
Frm 00062
Fmt 4703
Number of
responses per
respondent
Number of
respondents
Sfmt 4703
Average burden
per response
(in hours)
1
1
5
0.5
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 9:00 a.m.–4:45 p.m. EDT,
April 24, 2013.
Place: CDC, Building 19, Rooms 245 and
246, 1600 Clifton Road NE., Atlanta, Georgia
30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 20 people. The
public is welcome to participate during the
public comment, which is tentatively
scheduled from 4:30 to 4:40 p.m. This
meeting is also available by teleconference.
Please dial (877) 496–4855 and enter code
4363556.
Purpose: The Subcommittee will provide
advice to the CDC Director through the ACD
on strategic and other health disparities and
health equity issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee members will
discuss CDC’s health equity work in the
environmental health and developmental
E:\FR\FM\21MRN1.SGM
21MRN1
]]>Agencies
[Federal Register Volume 78, Number 55 (Thursday, March 21, 2013)]
[Notices]
[Page 17410]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panels (SEP): Initial review
The meeting announced below concerns Epi-Centers for the Prevention
of Healthcare-Associated Infections, Antimicrobial Resistance and
Adverse Events, Funding Opportunity Announcement (FOA) CK11-
0010301SUPP13, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 1:00 p.m.-4:00 p.m., May 8, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Epi-Centers for the Prevention of Healthcare-
Associated Infections, Antimicrobial Resistance and Adverse Events,
FOA CK11-0010301SUPP13''.
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-06436 Filed 3-20-13; 8:45 am]
BILLING CODE 4163-18-P
